liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Digoxin and mortality in atrial fibrillation: A prospective cohort study
Linköping University, Department of Medical and Health Sciences, Cardiology. Linköping University, Faculty of Health Sciences.
2007 (English)In: European Journal of Clinical Pharmacology, ISSN 0031-6970, E-ISSN 1432-1041, Vol. 63, no 10, 959-971 p.Article in journal (Refereed) Published
Abstract [en]

Objective: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study showed that rhythm-control treatment of patients with atrial fibrillation (AF) offered no survival advantage over a rate-control strategy. In a subgroup analysis of that study, it was found that digoxin increased the death rate [relative risk (RR)=1.42), but it was suggested that this may have been attributable to prescription of digoxin for patients at greater risk of death, such as those with congestive heart failure (CHF). No study has investigated a priori the effect of digoxin on mortality in patients with AF. This study aimed to address this question. Methods: Using data from the Registry of Information and Knowledge about Swedish Heart Intensive care Admissions (RIKS-HIA), we studied the 1-year mortality among patients admitted to coronary care units with AF, CHF, or AF+CHF with or without digoxin (n=60,764) during 1995-2003. Adjustment for differences in background characteristics and other medications and treatments was made by propensity scoring. Results: Twenty percent of patients with AF without CHF in this cohort were discharged with digoxin. This group had a higher mortality rate than the corresponding group not given digoxin [adjusted RR 1.42 (95% CI 1.29-1.56)], whereas no such difference was seen among patients with CHF with or without AF, although these patients had a nearly three-times higher mortality. Conclusion: The results suggest that long-term therapy with digoxin is an independent risk factor for death in patients with AF without CHF. © 2007 Springer-Verlag.

Place, publisher, year, edition, pages
2007. Vol. 63, no 10, 959-971 p.
Keyword [en]
Digoxin, Atrial fibrillation, Heart failure, Mortality, RIKS-
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-40762DOI: 10.1007/s00228-007-0346-9Local ID: 54063OAI: diva2:261611
Available from: 2009-10-10 Created: 2009-10-10 Last updated: 2014-01-17Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Stenestrand, Ulf
By organisation
CardiologyFaculty of Health Sciences
In the same journal
European Journal of Clinical Pharmacology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 23 hits
ReferencesLink to record
Permanent link

Direct link